Edition:
Deutschland

Pain Therapeutics Inc (PTIE.OQ)

PTIE.OQ on NASDAQ Stock Exchange Global Select Market

10.27USD
18 May 2018
Change (% chg)

$-0.14 (-1.34%)
Prev Close
$10.41
Open
$10.47
Day's High
$10.47
Day's Low
$10.18
Volume
7,770
Avg. Vol
109,890
52-wk High
$12.80
52-wk Low
$3.10

PTIE.OQ

Chart for PTIE.OQ

About

Pain Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on drug development efforts on disorders of the nervous system, such as chronic pain. The Company's lead drug candidate, REMOXY, is an abuse-deterrent, oral formulation of oxycodone (CII). The Company's other products is FENROCK. REMOXY is a... (more)

Buy/Sell

Sell Hold Buy
4.00 Mean rating from 1 analysts

Overall

Beta: 2.17
Market Cap(Mil.): $28.03
Shares Outstanding(Mil.): 6.60
Dividend: --
Yield (%): --

BRIEF-Durect Announces FDA Advisory Committee Meeting For Remoxy Er

* DURECT ANNOUNCES FDA ADVISORY COMMITTEE MEETING FOR REMOXY® ER

BRIEF-Pain Therapeutics Announces FDA Advisory Committee Meeting For Remoxy ER

* PAIN THERAPEUTICS ANNOUNCES FDA ADVISORY COMMITTEE MEETING FOR REMOXY ER®

BRIEF-FDA Accepts Remoxy NDA For Review, Sets PDUFA Date Of Aug 7, 2018

* FDA ACCEPTS REMOXY® NDA FOR REVIEW, SETS PDUFA DATE OF AUGUST 7, 2018

BRIEF-Pain Therapeutics Resubmits New Drug Application For Remoxy ER

* PAIN THERAPEUTICS RESUBMITS NEW DRUG APPLICATION FOR REMOXY® ER, AN ABUSE-DETERRENT, EXTENDED-RELEASE DRUG CANDIDATE FOR THE TREATMENT OF CHRONIC PAIN

BRIEF-Pain Therapeutics Signs On Demand Sales Agreement With JonesTrading Institutional Services

* PAIN THERAPEUTICS SAYS ON FEB 8, CO ENTERED INTO AN ATM CAPITAL ON DEMAND SALES AGREEMENT WITH JONESTRADING INSTITUTIONAL SERVICES LLC - SEC FILING

BRIEF-Pain Therapeutics Inc QTRLY ‍Net Loss Per Share $0.37​

* PAIN THERAPEUTICS INC QTRLY ‍NET LOSS PER SHARE $0.37​ Source text: [http://bit.ly/2nGTz7J] Further company coverage:

BRIEF-Pain Therapeutics Reports Positive Results From Nasal Abuse Potential Study With Remoxy

* PAIN THERAPEUTICS REPORTS POSITIVE TOP-LINE RESULTS FROM NASAL ABUSE POTENTIAL STUDY WITH REMOXY™

BRIEF-Pain Therapeutics Reports Positive Regulatory Meeting For Remoxy

* PAIN THERAPEUTICS REPORTS POSITIVE REGULATORY MEETING FOR REMOXY™

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie +0.03%
Rohstoffe +0.31%
Industrie -0.07%
Konjunktur abhängige Waren & Dienstleistungen -0.44%
Konjunktur unabhängige Waren & Dienstleistungen -0.55%
Finanzindustrie +0.23%
Pharma -0.34%
Technologie -0.57%
Telekommunikation -0.07%

Nachrichten aus der Wirtschaft